ADVFN Logo ADVFN

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Krystal Biotech Inc

Krystal Biotech Inc (KRYS)

181.10
-5.79
(-3.10%)
Cerrado 25 Febrero 3:00PM
181.10
0.00
( 0.00% )
Pre Mercado: 3:26AM

Calls

StrikeCompraVentaUltimo PrecioP. MedioVariaciónVariación %VolumeInt AbiertoÚltimo Operado
130.0050.6053.900.0052.250.000.00 %00-
135.0045.9049.000.0047.450.000.00 %00-
140.0040.8044.000.0042.400.000.00 %00-
145.0036.1039.300.0037.700.000.00 %00-
150.0030.2034.5036.0032.350.000.00 %00-
155.0031.0035.5033.5833.250.000.00 %00-
160.0022.5025.8028.7024.150.000.00 %0203-
165.0022.0026.5022.0524.250.000.00 %061-
170.0018.0022.4020.0020.200.000.00 %0310-
175.0011.0014.5016.0012.750.000.00 %01,013-
180.008.0011.5010.629.75-2.78-20.75 %110125/2/2025
185.005.409.5010.707.45-0.000.00 %053-
190.003.107.305.535.20-1.97-26.27 %5017225/2/2025
195.003.006.702.404.850.000.00 %02-
200.000.504.702.202.60-1.70-43.59 %12125/2/2025
210.001.302.800.002.050.000.00 %00-
220.000.102.551.501.3250.000.00 %01-

Su centro para precios en tiempo real, ideas y debates en vivo

Puts

StrikeCompraVentaUltimo PrecioP. MedioVariaciónVariación %VolumeInt AbiertoÚltimo Operado
130.000.002.250.000.000.000.00 %00-
135.000.002.300.000.000.000.00 %00-
140.001.001.501.001.250.000.00 %02-
145.0010.422.9010.426.660.000.00 %01-
150.000.353.0010.901.6750.000.00 %0221-
155.000.152.903.051.5250.000.00 %05-
160.000.452.902.501.6750.000.00 %0200-
165.000.955.000.002.9750.000.00 %00-
170.000.504.708.002.600.000.00 %02-
175.002.705.104.003.900.000.00 %035-
180.005.909.505.257.700.000.00 %04-
185.008.3012.108.1010.200.9513.29 %1425/2/2025
190.007.7012.009.009.850.000.00 %01-
195.0011.2015.400.0013.300.000.00 %00-
200.0018.8022.300.0020.550.000.00 %00-
210.0027.6030.700.0029.150.000.00 %00-
220.0031.5035.500.0033.500.000.00 %00-

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ENVBEnveric Biosciences Inc
US$ 2.59
(119.49%)
6.05M
PITAHeramba Electric PLC
US$ 0.7882
(113.60%)
7.87M
BSBKBogota Financial Corporation
US$ 12.40
(56.57%)
93
SMCXDefiance Daily Target 2X Long SMCI ETF
US$ 106.56
(53.94%)
171.67k
GBBKGlobal Blockchain Acquisition Corporation
US$ 17.53
(53.79%)
4
ADVMAdverum Biotechnologies Inc
US$ 1.73
(-58.81%)
21
HCATHealth Catalyst Inc
US$ 2.24
(-54.75%)
3
CSPICSP Inc
US$ 9.12
(-41.87%)
3
SRBKSR Bancorp Inc
US$ 7.01
(-41.83%)
1
SYRESpyre Therapeutics Inc
US$ 12.13
(-41.26%)
201
PITAHeramba Electric PLC
US$ 0.7882
(113.60%)
7.87M
ENVBEnveric Biosciences Inc
US$ 2.59
(119.49%)
6.05M
HCTIHealthcare Triangle Inc
US$ 0.5823
(53.24%)
4.5M
ONVOOrganovo Holdings Inc
US$ 1.53
(20.47%)
2.74M
QVCGAQVC Group Inc
US$ 0.4515
(17.58%)
2.56M

KRYS Discussion

Ver más
Monksdream Monksdream 4 meses hace
KRYS. Under $200
👍️0
Monksdream Monksdream 7 meses hace
KRYS new 52 week high
👍️0
Monksdream Monksdream 10 meses hace
KRYS 10Q due 5/6
👍️0
Monksdream Monksdream 11 meses hace
KRYS over $30
👍️0
Monksdream Monksdream 12 meses hace
KRYS new 52 week high
👍️0
Monksdream Monksdream 2 años hace
From Cathie Wood
A Novel Gene Therapy Promises Relief For A Rare Genetic Skin Disorder
ARK Invest_Illustration_Pierce Jamieson_Final_Circle 400 px By Pierce Jamieson | @PierceARK
Research Associate
Recently, the US Food and Drug Administration (FDA) approved Krysta Biotech’s (KRYS) groundbreaking advance1 in gene therapy, Vyjuvek, to treat wounds in patients suffering from dystrophic epidermolysis bullosa (DEB), a rare and serious genetic skin disorder caused by mutations in the collagen Type VII alpha 1 chain (COL7A1) gene. As the first FDA-approved gene therapy for DEB, Vyjuvek is a significant breakthrough.

Vyjuvek uses a genetically modified HSV-1 to deliver normal copies of the COL7A1 gene to wounds, restoring the integrity of the skin with fibrils that hold skin layers together. Treated with Vyjuvek, 65% of wounds closed completely.
👍️0
wiredawg wiredawg 3 años hace
Moving nicely today...
👍️0
wiredawg wiredawg 3 años hace
Looking at the few posts here there seems to be no real commitment here...any thoughts on KRYS? Hype or something brewing?
👍️0
wiredawg wiredawg 3 años hace
In the last 3 months, 5 ranked analysts set 12-month price targets for KRYS. The average price target among the analysts is $125.00. Analysts compare their price target to the current market price of the stock to determine how much potential upside or downside movement there could be in the stock price. High $140 Low $111

👍️0
wiredawg wiredawg 3 años hace
30 Nov Tues releases this PR during evening after market close:

https://ir.krystalbio.com/news-releases/news-release-details/krystal-biotech-announces-pricing-200-million-public-offering
👍️0
wiredawg wiredawg 3 años hace
29 Nov Mon after market closes release this PR:

https://ir.krystalbio.com/news-releases/news-release-details/krystal-biotech-announces-proposed-200-million-public-offering
👍️0
wiredawg wiredawg 3 años hace
29 Nov Monday pre-market news release, great move pre-market approx 7am and so far holding fairly well:

https://ir.krystalbio.com/news-releases/news-release-details/krystal-biotech-announces-positive-topline-results-gem-3-pivotal
👍️0
wiredawg wiredawg 3 años hace
This caught my eye on Monday, the huge move off the PR...I'm guessing here saw the same. Any real thoughts regarding the company and this PR. I have not gotten a chance to dig into it. Hoping to have somm DD done over the weekend.
👍️0
wiredawg wiredawg 3 años hace
Holding well so far, why the pretty hard drop?
👍️0
wiredawg wiredawg 3 años hace
Why are you surprised? Serious question, not being impudent...
👍️0
rynlrt rynlrt 3 años hace
200 million dollar offering. Won't be surprised to see it drop pretty hard when the market opens
👍️0
Fofo812 Fofo812 3 años hace
Surprised it held up this long
👍️0
crudeoil24 crudeoil24 3 años hace
Large tutes holdings. Some taking huge gains before years end.
👍️0
rynlrt rynlrt 3 años hace
Not sure this kind of gain is sustainable. May see a big pullback
👍️0
Fofo812 Fofo812 3 años hace
3rd post
👍️0
crudeoil24 crudeoil24 3 años hace
Krystal Biotech shares are trading higher after the company announced its GEM-3 trial met its primary endpoint.
👍️0
Trophy Trophy 5 años hace
..
👍️0